We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
-0.5%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$75.5M
AUM Growth
+$8.01M
(+12%)
Cap. Flow
+$8.15M
Cap. Flow
% of AUM
10.79%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
120
New
37
Increased
26
Reduced
20
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$1.8M |
| 2 |
Cigna
CI
|
+$1.51M |
| 3 |
AbbVie
ABBV
|
+$1.05M |
| 4 |
Range Resources
RRC
|
+$1.01M |
| 5 |
UnitedHealth
UNH
|
+$973K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.74M |
| 2 |
Voyager Therapeutics
VYGR
|
+$1.64M |
| 3 |
Baxter International
BAX
|
+$1.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.25M |
| 5 |
ServiceNow
NOW
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.39% |
| 2 | Energy | 5.97% |
| 3 | Technology | 5.96% |
| 4 | Industrials | 3.87% |
| 5 | Communication Services | 3.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CALL
Eli Lilly
LLY
$1.06T
| – | – |
-13,800
| Closed | -$1.11M |
|
102
Merck
MRK
$318B
| – | – |
-10,440
| Closed | -$622K |
|
103
Micron Technology
MU
$988B
| – | – |
-43,593
| Closed | -$775K |
|
|
104
ServiceNow
NOW
$128B
| – | – |
-74,985
| Closed | -$1.19M |
|
105
PUT
Regeneron Pharmaceuticals
REGN
$80.5B
| – | – |
-600
| Closed | -$241K |
|
106
Starwood Property Trust
STWD
$6.09B
| – | – |
-17,160
| Closed | -$386K |
|
107
Visa
V
$676B
| – | – |
-13,901
| Closed | -$1.15M |
|
108
Vipshop
VIPS
$7.52B
| – | – |
-57,601
| Closed | -$845K |
|
|
PXD
109
DELISTED
Pioneer Natural Resource Co.
PXD
| – | – |
-6,132
| Closed | -$1.14M |
|
|
SPLK
110
DELISTED
Splunk Inc
SPLK
| – | – |
-11,471
| Closed | -$673K |
|
|
HRC
111
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-2,874
| Closed | -$178K |
|
|
MDCO
112
CALL
DELISTED
Medicines Co
MDCO
| – | – |
-6,100
| Closed | -$230K |
|
|
JUNO
113
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – |
-18,376
| Closed | -$551K |
|
|
DMTX
114
DELISTED
Dimension Therapeutics, Inc
DMTX
| – | – |
-9,885
| Closed | -$79K |
|
Similar funds
SWM
ACM
ECAU
SL
DII
FIM
EM
BHC
Partner Investment Management's Q4 2016 Portfolio in Review
As of Q4 2016, Partner Investment Management held 120 positions worth $75.5M, up 12% from $67.5M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Partner Investment Management deployed $8.15M of net new capital in Q4 2016, opening 37 new positions and adding to 26 existing holdings. Its largest new stake was Elevance Health: 13,462 shares worth $1.94M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 42% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Voyager Therapeutics, an estimated $1.64M trimmed.
- Partner Investment Management's largest Q4 2016 buy was Elevance Health: 13,462 shares worth $1.94M.
- Partner Investment Management added most to Cigna in Q4 2016, an estimated $1.51M increase.
- Partner Investment Management's biggest Q4 2016 reduction was Voyager Therapeutics, cutting an estimated $1.64M.
- Partner Investment Management fully exited Apple in Q4 2016, selling an estimated $1.74M.
- Partner Investment Management's ten largest holdings make up 34% of its $75.5M portfolio in Q4 2016.
- Partner Investment Management opened 37 new positions and closed 30 in Q4 2016.
- Partner Investment Management's portfolio value rose 12% quarter-over-quarter to $75.5M.
Based on Partner Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.